Search - tctmd.com

Presenter: Hirotoshi Watanabe, Kyohei Yamaji, Yoshimitsu Soga, Shinichi Shirai, Kenji Ando, Koyu Sakai, Katsuhiro Kondo, Masashi Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Masakiyo Nobuyoshi

January 03, 2012

Presentation TCT 2012

Statin Therapy Reduces Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Presenter: Masahiro Natsuaki, Takeshi Morimoto, Yutaka Furukawa, Satoshi Shizuta, Toru Kita, Takeshi Kimura

January 03, 2012

News Industry News

Tryton Announces DRG Reimbursement Code for Side Branch Stent in Germany

December 21, 2011

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

Advertisement

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

OrbusNeich’s Genous™ Stent Is a Safe and Effective Option in Patients with ST-Segment Elevation Myocardial Infarction (STEMI)

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

Statins Reduce Late Restenosis After SES Implantation

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

Las Estatinas Reducen la Re-estenosis Tardía tras el Implante de un SLS

4000th Patient Treated With Innovative Tryton Side Branch Stent

Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study

Eurocor GmbH announces presentation of Valentines Trial II results at CRT2012

Eurocor announces first insights of the Freeway Stent Study at LINC Congress

Eurocor announces treatment of First Patients in International Randomized Freeride Study

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Use Of Paclitaxel-Eluting Stents Reduces Target Lesion Revascularization for Dialysis Patients.

Statin Therapy Reduces Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Tryton Announces DRG Reimbursement Code for Side Branch Stent in Germany

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content